2 completed. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Donepezil (Aricept®): new trials by email Literature Review of Donepezil (Aricept®) trials Research Report on Donepezil (Aricept®)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phenserine on the Alzheimer's Treatment Horizon, Study 1 Phenserine, Donepezil (Aricept®) - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Completed | Helse Stavanger HF | 16 | 2025-02-01 | 2026-05-04 |
| Corticolimbic Degeneration and Treatment of Dementia Memantine (Namenda®), Donepezil (Aricept®) - Dementia | Phase 4 | Completed | Washington University School of Medicine | 39 | 2004-11-01 | 2018-09-11 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dementia (1)
Helse Stavanger HF (1) · Washington University School of Medicine (1)
Norway (1)
John Morris, MD (1)